Who makes oseltamivir [Tamiflu]?

oseltamivir [Tamiflu] is developed by Genentech, Inc..

What development phase is oseltamivir [Tamiflu] in?

oseltamivir [Tamiflu] is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

oseltamivir [Tamiflu]

Genentech, Inc. · FDA-approved active Small molecule Quality 2/100

At a glance

Generic name	oseltamivir [Tamiflu]
Sponsor	Genentech, Inc.
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

oseltamivir [Tamiflu] CI brief — competitive landscape report
oseltamivir [Tamiflu] updates RSS · CI watch RSS
Genentech, Inc. portfolio CI